DJ Biogen Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ slipped 1.92% to $192.23 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.26% to 7,599.96 and the Dow Jones Industrial Average rising 0.09% to 51,078.88.
This was the stock's third consecutive day of losses.
Biogen Inc. closed 6.67% short of its 52-week high of $205.97, which the company achieved on May 13th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.81% to $223.51, Pfizer Inc. $(PFE)$ fell 2.10% to $25.63, and AbbVie Inc. $(ABBV)$ fell 2.20% to $212.93.
Trading volume (841,496) remained 389,257 below its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 1, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 01, 2026 16:58 ET (20:58 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments